Funding Priority

Invest in People to Find Cures

Our battle against cancer is only as effective as the people we engage in the fight — our exceptional team of scientists and care providers who are driven by a desire to do remarkable things for the good of others. We must continue to cultivate these leaders across research, education, prevention and patient care. Our best and brightest faculty are coveted by other leading cancer centers. As a result, we must enhance strategic efforts to retain top faculty and to recruit the next generation of lifesaving scientists and clinicians.

UNC Lineberger Comprehensive Cancer Center

    From the Outside In

    With convergence across disciplines so embedded in our culture, solutions can come from unexpected collaborations that you may not find elsewhere. For instance, brain tumor treatment options can be greatly enhanced when a neurosurgeon joins forces with a pharmaceutical scientist.

    Tumors known as glioblastomas are notoriously difficult to treat, with fewer than 10 percent of patients surviving five years. Through collaborations with Matt Ewend, M.D., who leads UNC Lineberger’s neuro-oncology group, UNC Eshelman School of Pharmacy’s Shawn Hingtgen, Ph.D., knew that these patients needed a different form of treatment to fight off this particularly virulent cancer.

    Building on existing stem cell technology, Dr. Hingtgen and his team of researchers re-engineered ordinary skin cells into extraordinary cancer-hunting stem cells that, paired with an anti-cancer drug, can destroy the small cancerous tendrils that surgery often leaves behind. Through novel research and engineering, he reprograms skin cells into therapeutic agents, a first in the treatment of cancer.

    With incredible minds, unwavering focus and a diversity of perspectives, we go beyond simply making great strides for our patients, but push the boundaries of everything treatment is and can be.

    Return to main pageOpens in new window

    More UNC Lineberger Funding Priorities

    Explore Stories

    Rich Preyer and Marilyn Jacobs Preyer

    Reducing Breast Cancer Disparities And Barriers To Care

    Rich Preyer and Marilyn Jacobs Preyer have donated $1 million to support UNC Lineberger Comprehensive Cancer Center’s Carolina Breast Cancer Study


    Grateful patient and husband establish breast cancer research fund

    Ensuring access to the most advanced care


    Deepening Our Understanding

    Using next generation sequencing to better understand COVID-19


    Precision Cancer Treatments

    "It's an exciting approach; we hit the tumor hard with little toxicity, leaving room for other therapy."

    Shelley Earp unc Lineberger

    Advancing Cancer Research and Care Across Carolina and the Globe

    As a nationally recognized cancer researcher and current director of UNC Lineberger Comprehensive Care Center, Shelton “Shelley” Earp is as comfortable in the lab as he is cheering for the Tar Heels in the Dean Dome.


    Breaking Down Precision Medicine

    UNC Lineberger designs, develops and delivers CAR-T therapy to to attack cancers.